Nateglinide
Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
Trade Name | Starlix |
---|---|
Common Name | Nateglinide |
Indication | type 2 diabetes mellitus |
Drug Class | Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives |